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Many studies have noted an increased prevalence of adverse drug reactions in the elderly population (Le Couteur and McLean, 1998; Greenblatt et al., 1982) . As the proportion of those over 65 years increases in the U.S. population (Administration on Aging, 2001) , an understanding of the frequency and etiology of adverse reactions in older individuals is becoming increasingly important. Multiple studies have suggested that pharmacokinetic changes with age may contribute to the increase in these adverse effects in the elderly. In particular, many studies have demonstrated a reduced clearance of CYP3A substrates in the elderly (Miglioli et al., 1990; Holazo et al., 1988; Greenblatt et al., 1991 Greenblatt et al., , 1983a Greenblatt et al., , b, 1984 Cotreau et al., 2004) . However in some studies, significant age-related changes in clearance are not observed (Hunt et al, 1992a; Gorski et al, 2003) .
Age-related changes in the pharmacokinetics of CYP3A substrates are likely to be multifactorial. Possible contributing causes include reduced expression of hepatic or enteric CYP3A protein, reduction in liver mass, and possibly reduction in hepatic blood flow (Schmucker, 1998; Kinirons and Crome, 1997; Cotreau et al, 2004) . CYP3A function in vivo also may be influenced by factors such as disease states, concurrent medications, diet, smoking, and genetics. Several investigators have evaluated the effect of age on hepatic CYP3A expression and function in vitro (Transon et al., 1996; George et al., 1995; Shimada et al., 1994; Hunt et al., 1992b; Schmucker et al., 1990; Patki et al., 2004) . Outcomes of these studies have been inconsistent, and a variety of limitations exist for this type of analysis, such as tissue sources and harvesting protocols (Warrington et al., 2000) . Rodent models have more consistently displayed a reduction in the clearance of CYP3A substrates with age in vivo (Barnhill et al., 1990) 
and in vitro
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JPET Fast Forward. Published on January 23, 2004 as DOI: 10.1124 at ASPET Journals on November 4, 2017 jpet.aspetjournals.org Downloaded from (Warrington et al., 2000) . However, many studies of age in rodent models were conducted prior to the availability of specific immunoinhibitory antibodies and index substrates for rodent CYPs. These early studies were thus limited in their ability to determine the involvement of individual CYP enzymes in specific reactions. Recent studies have suggested that triazolam biotransformation may be largely mediated by CYP3A isoforms in rodents (Perloff et al., 2000) . Thus, this reaction may be useful for evaluating age-related changes in CYP3A activity.
The in vitro studies discussed above have been limited to hepatic CYP3A. While CYP3A is most predominantly expressed in the liver, the importance of enteric CYP3A activity is increasingly recognized (Thummel and Wilkinson, 1998; Tsunoda et al., 1999) . Differences in enteric CYP3A activity are likely to contribute, in part, to the interindividual variability observed in the clearance of same CYP3A substrates after oral dosage. The effect of age on enteric CYP3A expression and activity is not well established. To our knowledge, only one study has examined the effect of age on intestinal CYP3A expression and found no change with age (Lown et al., 1997) .
However, age differences were not the primary focus of this study, and few older subjects were included.
Using western blot analysis to evaluate CYP3A expression and triazolam testosterone concentrations and the expression of NADPH reductase in the liver, intestine and kidney.
This article has not been copyedited and formatted. The final version may differ from this version. et al, 2003) . Four old rats were removed from the study due to the development of infection (n=1), superficial gross tumors (n=2) or hepatomegaly, (n=1). Rats were housed in the animal facilities at Tufts University School of Medicine for an additional 1-2 months in a 12hr:12hr light-dark cycle. Food and water were provided ad libitum.
Animals were sacrificed by decapitation. Livers and kidneys were stored on dry ice for ~30 min and then stored at -80°C until microsomal preparation. Intestinal microsomes were prepared directly after sacrifice.
Reagents: Triazolam was purchased from Sigma Laboratories, while its metabolites were kindly provided by Pharmacia and Upjohn Co. (Kalamazoo, MI). Antibodies, rat cDNAexpressed enzymes and other reagents were purchased from commercial sources.
Microsomal preparations
Intestinal microsomes: Intestinal microsomes were prepared as previously described (Kotegawa et al., 2002; Cotreau et al., 2000 Cotreau et al., , 2001 . Briefly, enterocytes were isolated from the proximal portion (35cm) of the rat small intestine using four solutions, designated as A, B, C and D. First, the intestinal segment was washed with Solution A (1.5mM KCl, 96mM NaCl, 27mM sodium citrate, 8mM KH 2 PO 4 , 5.6mM Na 2 HPO 4 and 40µg/ml phenylmethylsulfonyl fluoride (PMSF), pH 7.4). Cells were then eluted from the intestinal wall using Solution B (phosphate buffered saline without calcium and This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on January 23, 2004 as DOI: 10.1124 at ASPET Journals on November 4, 2017 jpet.aspetjournals.org Downloaded from magnesium: 1.5mM ethylenediamine tetracetic acid (EDTA), 0.5mM dithiothreitol and 40µg/ml PMSF, pH 7.4) and were washed twice in Solution C (5mM histidine, 0.25M sucrose, 0.5mM Na 2 EDTA and 40µg/ml PMSF, pH 7.4). Samples were homogenized using a loose-fitting Dounce homogenizer. Samples were then centrifuged for 10 min at 15,000g and the supernatants were removed and placed on ice. The pellet was resuspended in Solution C and centrifuged at 15,000g for an additional 10 min. The second supernatant was added to the first and 2.5ml CaCl 2 was added. After a 20min incubation on ice, samples were centrifuged at 25,000g for 10 min and pellets were resuspended in 0.5ml 80% 0.1M potassium phosphate buffer with Solution D (20% glycerol). Microsomes were stored at -80˚C until use.
Hepatic and renal microsomes: Hepatic and renal microsomes were prepared by differential centrifugation, as previously described (Warrington et al., 2000; Lake, 1987) .
Briefly, approximately one lobe from the liver and one kidney from each rat were homogenized in a 0.05M potassium phosphate buffer containing 0.15M KCl and 0.25M sucrose. Samples were centrifuged at 10,000 rpm for 22 min at 4˚C. Supernatants were then centrifuged for an additional 70min at 33,000rpm at 4°C. The pellets were then homogenized in 0.1M potassium phosphate buffer containing 20% glycerol and stored at -80°C until use.
For all microsomal preparations, protein concentrations were determined using the bicinchoninic acid protein assay (Pierce Chemical Co., Rockford, IL) with albumin as the protein standard. 
In vitro biotransformation of triazolam
Triazolam hydroxylation was examined in intestinal and hepatic microsomes (von Moltke et al., 1996; Perloff et al., 2000) . Increasing concentrations of triazolam (0-750µM) were incubated with microsomes (0.25 and 0.1mg/ml for liver and intestine microsomes, respectively) in the presence of a NADPH-regenerating cofactor system (6.3mM MgCl 2 , 0. 
Chemical and antibody inhibition of triazolam hydroxylation
Ketoconazole and immunoinhibitory antibodies were used to evaluate the role of CYP3A in the biotransformation of triazolam in the aging male rat.
The human CYP3A inhibitor, ketoconazole (2.5µM), was incubated with TRZ (250µM) in the presence of either hepatic (0.25mg/ml for TRZ) or intestinal (0.1mg/ml for TRZ) microsomes. Reactions were performed in duplicate and as described above.
The samples were then analyzed by HPLC.
This article has not been copyedited and formatted. The final version may differ from this version. For immunoinhibition studies, microsomes (10µg) were preincubated with TRZ at 37°C for 30 min in the presence of either an antirat CYP antibody (100µg; CYP1A1/2, CYP2B1/2, CYP2C11, CYP2E1 and CYP3A1/2; Gentest, Woburn, MA), an appropriate serum control (rabbit or goat; 100µg) or 50mM potassium phosphate buffer. An NADPHregenerating system was added and samples were incubated as described above. As negative controls, serum controls and samples containing 50mM potassium phosphate buffer were included. TRZ was incubated with rat hepatic microsomes as a positive control. Reactions were subjected to HPLC analysis.
HPLC analysis
Samples were analyzed by HPLC, as previously described (Perloff et al., 2000; von Moltke et al., 1996) . Triazolam, phenacetin, α -and 4-hydroxylated products were separated using a stainless steel 15cm x 3.9mm reverse phase C 18 NovaPak column (Waters Associates, Milford, MA) with a mobile phase of 70% 10mM potassium phosphate buffer, 20% acetonitrile, 10% methanol at a flow rate of 1.4ml/min. The column effluent was analyzed at a wavelength of 220nm.
Data analysis of TRZ hydroxylation
For both reactions, chromatographic peak height ratios were generated. These ratios were converted into reaction velocities (nmols/min/mg protein) using a standard curve of known, increasing concentrations of metabolites subjected to the same incubation conditions. Metabolite formation rates for hepatic and intestinal incubations were fit to appropriate kinetic models by nonlinear regression. A single-enzyme Michaelis-Menten kinetic model was used for the formation of both metabolites in the intestine, 4-OH-TRZ formation in rat liver for all age groups and for α -OH-TRZ formation in the old rat liver:
in which V represents the reaction velocity; S represents the substrate concentration, V max denotes the maximal reaction velocity and K m represents the substrate concentration at which 50% of V max is achieved. 
Western blot analysis of CYP3A expression in rat
Hepatic (0.94-8.0µg), intestinal (1.3-12.3µg) and renal (50-98µg) microsomal protein was evaluated for CYP3A expression, as described previously for hepatic and intestinal microsomes (Cotreau et al., 2000 (Cotreau et al., , 2001 . Briefly, samples were loaded onto a 7.5% polyacrylamide gel alongside tissue-specific standards and separated by exposure to 120V for 1.5 hr using a running buffer (0.19M glycine, 250mM Tris-base, 0.1% SDS).
Protein was transferred onto a nitrocellulose membrane at 100V for 1 hour at 4ºC using a transfer buffer (0.19M glycine, 250mM Tris-base, 20% methanol). After a 1 min exposure to gel fixation buffer (50% methanol, 10% glacial acetic acid), membranes were washed with 1xTBS-Tween (0.15M NaCl, 40mM Tris-HCl, 40mM Tris-base, 0.06% Tween). After incubation with 3% blotto (dry nonfat milk in 1xTBS-Tween) for 1hr at 25˚C, membranes were probed with an antirat CYP3A1/2 antibody (1:3000; Xenotech, Kansas City, KS) for 16-18hr at 4˚C and 1hr at 25˚C. Membranes were washed with 1xTBS-Tween, incubated with 3% blotto for 30min at 25˚C and reprobed with a donkey antirabbit secondary antibody coupled to horseradish peroxidase (Pierce, Rockford, IL) for 1 hr at 25˚C. The membranes were then exposed to a chemilluminescent substrate for detection and analyzed using a Kodak imager and Kodak 1D image software.
NADPH expression analysis in rat microsomal preparations
NADPH reductase expression was also evaluated in these tissues. Membranes that were probed with an antirat CYP3A antibody were stripped and reprobed with an antirat NADPH reductase (1:3000; Gentest Corp., Woburn, MA) and a donkey antigoat secondary antibody that was linked to horseradish peroxidase (1:10,000; Santa Cruz This article has not been copyedited and formatted. The final version may differ from this version. Biotechnology; Santa Cruz, CA). The same immunoblotting conditions described for CYP3A expression were used to evaluate NADPH reductase expression.
For stripping, blots were subjected to stripping buffer (0.2M glycine, 0.1% sodium dodecyl sulfate (SDS) and 1% Tween-20, pH 2.2) for one hour and washed thoroughly with ddH 2 O and 1xTBS-Tween before reprobing. If the net intensity of the bands probed with the NADPH reductase antibody were outside the range of the standard curve, samples were reloaded at lower protein concentrations and subjected to the same conditions described above for CYP3A expression analysis.
Data analysis for immunoblotting
Using Kodak 1D software, the relative quantities of CYP3A or NADPH reductase content were assessed by the band's net intensity, the pixels*area-background at the perimeter. These values were compared to those determined for the tissue-specific microsomal protein standards, which represent serially diluted microsomal protein and loaded alongside of the samples. Standard curves in which the net intensity of the standard vs. the amount of microsomal protein were generated. Data points were fit to either y=mx or y=mx A in which x represents the microsomal protein amount loaded, y reflects the net intensity of each band and A is an exponent.
Plasma concentrations of testosterone
Trunk blood was collected into heparinized tubes and stored at -20ºC. Samples (~1ml; n=10 for young and intermediate; n=7 for old) were evaluated for free testosterone concentrations by immunoassay (Olubodun et al., 2003) .
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Results

In vitro hydroxylation of triazolam in the rat liver
Both 4-OH-TRZ and α -OH-TRZ were formed by rat liver microsomes.
Metabolite formation rates declined with age for both metabolites ( The relative contribution of each pathway to the net Cl int changed with age. While 4-OH-TRZ formation was the predominant pathway in the young livers, both metabolites had similar relative CL int values in the old livers. Normalization of the net Cl int per mg liver or the total liver weight had little impact on age-related trends.
In vitro hydroxylation of triazolam in the rat intestine
Both hydroxylated products of TRZ biotransformation were produced by rat intestinal microsomes. Metabolite formation for both α -OH and 4-OH-TRZ was best fit to a single-enzyme Michaelis-Menten model.
The net Cl int of TRZ in rat intestinal microsomes was 10% of that observed using rat liver microsomes. This reduced Cl int was largely attributable to an increase in K m values for both metabolites ( Age-related changes in TRZ hydroxylation by intestinal microsomes were small, and not statistically significant ( Figure 1 , Table 1 ).
Chemical and antibody inhibition of triazolam hydroxylation
Among five immunoinhibitory antibodies (polyclonal antirat CYP1A1/2, 2B1/2, 2C11, 2E1 and CYP3A1/2), only the antirat CYP3A1/2 antibody inhibited TRZ biotransformation in the liver and intestine.
In liver microsomes, the antirat CYP3A1/2 inhibited both 4-OH-and α -OH-TRZ formation in the old animals less than the other age groups (SNK, p<0.05). Similar findings were observed at a higher antibody concentration (1:50; data not shown). In intestinal microsomes, the CYP3A1/2 antibody inhibited TRZ hydroxylation in all age groups to a similar degree for both metabolites, although some statistical differences were found ( Figure 2 ). For both hepatic and intestinal samples, the antibody did not fully inhibit either α -OH-or 4-OH-TRZ formation.
Ketoconazole inhibited metabolite formation in both the liver and intestine (Figure 3 ). Age-related differences in chemical inhibition were observed in the liver (Kruskal-Wallis ANOVA, p<0.05), but not in the intestine. Ketoconazole (2.5µM)
inhibited metabolite formation to a lesser degree in the old livers (Dunn's, p<0.05).
Western blot analysis of CYP3A expression in liver, intestine and kidneys
The polyclonal antirat CYP3A1/2 antibody detected two bands in the rat liver, (the lower band). The relative amounts of these isoforms differed among the three tissues. While CYP3A1 and -3A2 isoforms were expressed in similar quantities in the liver, CYP3A2 was the predominant isoform in the kidney and the intestine. Also, while there was a strong correlation between these isoforms in the liver (r 2 =0.68), there is only a weak correlation with the other two tissues (r 2 =0.35 for the intestine and r 2 =0.23 for the kidney).
After normalizing renal, intestinal and hepatic CYP3A expression to a liver microsomal standard, we found that the liver expressed the highest levels of CYP3A.
Intestinal CYP3A expression was approximately 25% of hepatic expression, while renal CYP3A was less than 1% in the liver.
The effect of age on CYP3A expression was tissue-dependent. In the rat livers, an age-related decline was observed in both CYP3A1 (ANOVA, p<0.005) and CYP3A2 
NADPH reductase expression in the liver, intestines and kidney
In all three tissues, the antirat NADPH reductase antibody identified one band at ~80kDa, which is consistent with the molecular weight of NADPH reductase. In all three tissues, this antibody also detected a second unidentified band of lower intensity (~100kDa).
An age-related decline in NADPH reductase expression was detected in all three tissues ( Figure 7) . However, these age-related trends did not reach statistical significance in the intestine (ANOVA, p=0.091) or kidney (ANOVA, p=0.06). Correlational analyses of hepatic, intestinal and renal NADPH reductase expression demonstrated no significant correlation between NADPH reductase expression across tissues.
Plasma testosterone in aging rats
Age-related differences were observed in free testosterone concentrations ( Figure   8 ; ANOVA, p<0.05). These differences reached statistical significance between the young and old groups (Student-Newman-Keuls, p<0.05), with or without inclusion of an outlying data point. The relative decrement in testosterone concentrations between young This article has not been copyedited and formatted. The final version may differ from this version. (Miglioli et al., 1990; Greenblatt et al., 1980 , 1983a , 1983b , Cotreau et al., 2004 . Although species differences have been identified between the male rat and humans, these similarities suggest that the study of age-related changes in the male rat may provide a framework for evaluating the mechanisms of agerelated differences in human CYP3A expression and function.
This article has not been copyedited and formatted. The final version may differ from this version. Age-related declines in NADPH reductase expression were evident in all three tissues. These findings were consistent with a previous study of NADPH reductase ontogeny in which Simmons and Kasper (1989) found that age-related changes in mRNA levels in the liver, intestine and kidney. Reduced hepatic NADPH expression with age may contribute to the age-related decrements in CYP3A function. However, these changes would not contribute to lower levels of immunoreactive CYP3A protein.
We also noted a reduction in free testosterone levels in our aging rats. The reduction in free testosterone levels was similar to the degree of decline in the intrinsic , 1998; Fujita et al., 1985 Fujita et al., , 1990a Kamataki et al., 1985; Patki et al, 2003) . However, correlations between testosterone concentrations and CYP3A activity were weak, suggesting that testosterone is not the only modulator of CYP expression in relation to age. Also, since CYP3A activity and expression changes in the aging male rat are likely to be tissue-dependent, a change in systemic hormone levels alone is unlikely to be the sole cause of changes in CYP activity. This suggests that either local hormone levels or differences in the regulation of CYP3A at these various sites may contribute to CYP3A modulation. Evaluation of age-related differences in CYP3A expression, V max values for triazolam hydroxylation, and NADPH reductase expression in females may provide more insight into the role of hormonal regulation.
Further study of the regulation of CYP3A expression is central to the understanding of age-related differences in CYP3A activity and examination into tissuespecific differences may help to elucidate factors that regulate CYP3A expression and function with age.
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